Did Peregrine just stepp into a partnership with Gilead right before us not even knowing it? Though the last time we seen this on a smaller scale with Ambit Biosciences they were bought out so lets see what happens....
plain as day it certainly says employment with Peregrine and Gilead beginning back in March of 2015
Experience Sr. Director Medical Affairs Peregrine Pharmaceuticals, Inc. March 2015 – Present (7 months)Tustin, CA
Director Clinical Research-Oncology and Inflammation Therapeutics Gilead Sciences July 2012 – Present (3 years 3 months)Foster City, CA
..... and Gilead brings in during that March 2014 timeframe, some key players, one or two from Novartis so we shall just have to wait and see this play out
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!